Zdrowie i gospodarka · 25/03/2019
FDA Publishes Draft Guidance for Rare Diseases: Natural History Studies for Drug Development
The FDA is releasing a draft guidance to help pharmaceutical companies design and conduct natural history studies for rare diseases, which can support the development of safe and effective treatments.
Source: Federal Register — Food and Drug AdministrationOpen original release →